CYP3A5 Polymorphism In Serbian Paediatric Epileptic Patients On Carbamazepine Treatment

CYP3A5 Polymorphism In Serbian Paediatric Epileptic Patients On Carbamazepine Treatment

Carbamazepine exhibits significant inter-individual variability in its efficacy and safety, which leads to unpredictable therapy outcomes for the majority of patients. Although its complex biotransformation depends on CYP3A5 activity, evidence of association between carbamazepine treatment outcomes...

Full description

Bibliographic Details
Main Authors: Milovanovic Dragana Dragas, Radosavljevic Ivan, Radovanovic Marija, Milovanovic Jasmina R., Obradovic Slobodan, Jankovic Slobodan, Milovanovic Dragan, Djordjevic Natasa
Format: Article
Language:English
Published: Sciendo 2015-06-01
Series:Serbian Journal of Experimental and Clinical Research
Subjects:
cyp3a5 polymorphism
serbian
epilepsy
carbamazepine
cyp3a5 polimorfizam
srpski
epilepsija
karbamazepin
Online Access:https://doi.org/10.1515/sjecr-2015-0012

Internet

https://doi.org/10.1515/sjecr-2015-0012

Similar Items